DEXAMETHASONE injection, solution

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

有效成分:

DEXAMETHASONE (UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)

可用日期:

Vedco, Inc.

INN（国际名称）:

DEXAMETHASONE

组成:

DEXAMETHASONE 2 mg in 1 mL

给药途径:

INTRAMUSCULAR

处方类型:

PRESCRIPTION

疗效迹象:

DEXAMETHASONE INJECTION 2 mg/mL is indcated for  the treatment of primary bovine ketosis an as an anti-inflammatory agent in the bovine and equine. As supportive therapy, DEXAMETHASONE INJECTION 2 mg/mL may be used in the management of vairious rheumatic, allergic dermatologic, and other diseases known to be responsive to anti-inflammatory corticosteroids.  DEXAMETHASONE INJECTION 2 mg/mL may be used intravenously as supportive therapy when an immeidate hormonal response is required. Bovine Ketosis DEXAMETHASONE INJECTION 2 mg/mL is offered for the treatment of primary ktosis.  The gluconeogenic effects of DEXAMETHASONE INJECTION 2 mg/mL, when administered intramuscularyly, are generally noted within the first 5 to 12 hours.  When DEXAMETHASONE INJECTION 2 mg/mL is used intravenously, the effects may be noted sooner.  Blood sugar levels rise to normal levels repidly and genreally rise to above normal levels within 12 to 24 hours.  Acetone bodies are reduce to normal concentrations usually witnin 24 hours.  Th

產品總結:

DEXAMETHASONE INJECTION 2 mg/mL, 100 mL multiple dose vials. Each mL contains :  2 mg dexamethasone; 500 mg polyethylene glycol 400; 9 mg benzyl alcohol, 1.8 mg methylparaben, and 0.2 mg propylparaben as preservatives; 4.75% alcohol; HCl to adjust pH to approximately 4.9; water for injection qs. TAKE TIME OBSERVE LABEL DIRECTIONS

授权状态:

Abbreviated New Animal Drug Application

产品特点

DEXAMETHASONE - DEXAMETHASONE INJECTION, SOLUTION
VEDCO, INC.
----------
DEXAMETHASONE INJECTION 2 MG/ML
SOLUTION FOR INTRAVENOUS OR INTRAMUSCULAR INJECTION
VETERINARY
CAUTIONFederal Law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION
DEXAMETHASONE INJECTION 2 mg/mL is a synthetic analogue of
prednisolone, having similar but
more potent anti-inflammatory therapeutic action and diversified
hormonal and metabolic effects.
Modification of the basic corticoid structure as achieved in
DEXAMETHASONE INJECTION 2
mg/mL offers enhanced anti-inflammatory effect compared to older
corticosteroids. The dosage of
DEXAMETHASONE INJECTION 2 mg/mL required is markedly lower than that
of prednisone and
prednisolone.
DEXAMETHASONE INJECTION 2 mg/mL is not species-specific; however, the
veterinarian should
read the sections on INDICATIONS, DOSAGE, SIDE EFFECTS,
CONTRAINDICATIONS,
PRECAUTIONS, and WARNINGS before this drug is used.
DEXAMETHASONE INJECTION 2 mg/mL is intended for _intravenous or
intramuscular_ administration.
Each mL contains 2 mg dexamethasone, 500 mg polyethylene glycol 400, 9
mg benzyl alcohol, 1.8 mg
methylparaben and 0.2 mg propylparaben as preservatives, 4.75%
alcohol, HCl to adjust pH to
approximately 4.9, water for injection q.s.
EXPERIMENTAL STUDIES
Experimental animal studies on dexamethasone have revealed it
possesses greater anti-inflammatory
activity than many steroids. Veterinary clinical evidence indicates
dexamethasone has approximately
twenty times the anti-inflammatory activity of prednisolone and
seventy to eighty times that of
hydrocortisone. Thymus involution studies show dexamethasone possesses
twenty-five times the
activity of prednisolone. In reference to mineralocorticoid activity,
dexamethasone does not cause
significant sodium or water retention. Metabolic balance studies show
that animals on controlled and
limited protein intake will exhibit nitrogen losses on exceedingly
high dosages.
ADMINISTRATION AND DOSAGE
Therapy with DEXAMETHASONE INJECTION 2 mg/